C J Girman

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Association of health-related quality of life and benign prostatic enlargement
    C J Girman
    Department of Epidemiology, Merck Research Laboratories, West Point, PA, USA
    Eur Urol 35:277-84. 1999
  2. ncbi Prediction of fracture in nursing home residents
    Cynthia J Girman
    Department of Epidemiology, Merck Research Laboratories, Blue Bell, Pennsylvania 19422, USA
    J Am Geriatr Soc 50:1341-7. 2002
  3. ncbi Measurement of distal forearm bone mineral density: can different forearm segments be used interchangeably ?
    A R Martin
    Merck Research Laboratories, West Point, PA 19486, USA
    J Clin Densitom 2:381-7. 1999
  4. ncbi The effects of hair loss in European men: a survey in four countries
    D Budd
    Department of Epidemiology, Merck Research Laboratories, BL 1 7, 10 Sentry Parkway, Blue Bell, PA 19422, USA
    Eur J Dermatol 10:122-7. 2000
  5. ncbi Low bone mineral density and risk of fracture in white female nursing home residents
    J M Chandler
    Department of Epidemiology, BL1 7, Merck Research Laboratories, PO Box 4, West Point, PA 19486 0004, USA
    JAMA 284:972-7. 2000
  6. ncbi Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes
    C J Girman
    Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, North Wales, PA 19454, USA
    Diabetes Obes Metab 12:766-71. 2010
  7. ncbi The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates
    K G Brodovicz
    Epidemiology, Merck Research Laboratories, Merck Sharp and Dohme Corp, North Wales, PA 19454, USA
    Diabet Med 28:1078-81. 2011
  8. ncbi Characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database
    B Cai
    Department of Epidemiology, Clinical Research, Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
    Int J Clin Pract 64:1601-8. 2010
  9. ncbi Health-related quality of life among patients with facial acne -- assessment of a new acne-specific questionnaire
    A R Martin
    Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    Clin Exp Dermatol 26:380-5. 2001
  10. ncbi Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
    M N Cook
    Department of Epidemiology, Merck Research Laboratories, West Point, PA 19486 0004, USA
    Diabet Med 24:350-8. 2007

Detail Information

Publications35

  1. ncbi Association of health-related quality of life and benign prostatic enlargement
    C J Girman
    Department of Epidemiology, Merck Research Laboratories, West Point, PA, USA
    Eur Urol 35:277-84. 1999
    ..To investigate the association of benign prostatic enlargement and health-related quality of life (HRQoL) assessed by validated questionnaires...
  2. ncbi Prediction of fracture in nursing home residents
    Cynthia J Girman
    Department of Epidemiology, Merck Research Laboratories, Blue Bell, Pennsylvania 19422, USA
    J Am Geriatr Soc 50:1341-7. 2002
    ..To investigate cross-validated methods of identifying patients at increased risk of fracture in nursing homes using readily available data...
  3. ncbi Measurement of distal forearm bone mineral density: can different forearm segments be used interchangeably ?
    A R Martin
    Merck Research Laboratories, West Point, PA 19486, USA
    J Clin Densitom 2:381-7. 1999
    ..Thus, different forearm sites may be used interchangeably for diagnostic purposes; however, the prognostic value of each site remains unknown...
  4. ncbi The effects of hair loss in European men: a survey in four countries
    D Budd
    Department of Epidemiology, Merck Research Laboratories, BL 1 7, 10 Sentry Parkway, Blue Bell, PA 19422, USA
    Eur J Dermatol 10:122-7. 2000
    ..The degree that hair loss is perceived as noticeable to others appears to be a significant contributor to these negative effects...
  5. ncbi Low bone mineral density and risk of fracture in white female nursing home residents
    J M Chandler
    Department of Epidemiology, BL1 7, Merck Research Laboratories, PO Box 4, West Point, PA 19486 0004, USA
    JAMA 284:972-7. 2000
    ..Low bone mineral density (BMD) is a strong risk factor for fracture in community-dwelling white women, but the relationship in white female nursing home residents, for whom fracture rates are highest, is less clear...
  6. ncbi Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes
    C J Girman
    Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, North Wales, PA 19454, USA
    Diabetes Obes Metab 12:766-71. 2010
    ..The aetiology of acute pancreatitis (AP) is complex, and many risk factors for AP are shared by patients with type 2 diabetes mellitus (T2DM). However, few have assessed risk factors for AP specifically in T2DM patients...
  7. ncbi The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates
    K G Brodovicz
    Epidemiology, Merck Research Laboratories, Merck Sharp and Dohme Corp, North Wales, PA 19454, USA
    Diabet Med 28:1078-81. 2011
    ..The aim of this analysis was to evaluate FINDRISC as a tool to characterize reduced β-cell function in individuals without known diabetes...
  8. ncbi Characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database
    B Cai
    Department of Epidemiology, Clinical Research, Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
    Int J Clin Pract 64:1601-8. 2010
    ..Characteristics of patients with type 2 diabetes mellitus (T2DM) taking sitagliptin were compared with patients taking other oral antihyperglycaemic agents (OAHA) in a large US insurance claims database...
  9. ncbi Health-related quality of life among patients with facial acne -- assessment of a new acne-specific questionnaire
    A R Martin
    Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    Clin Exp Dermatol 26:380-5. 2001
    ..The use of the Acne-QoL should aid physicians in understanding the impact of facial acne on young adults, and may be useful in assessing therapeutic effects in acne clinical trials...
  10. ncbi Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
    M N Cook
    Department of Epidemiology, Merck Research Laboratories, West Point, PA 19486 0004, USA
    Diabet Med 24:350-8. 2007
    ..To describe initial achievement of glycaemic targets and subsequent hyperglycaemia in patients with Type 2 diabetes managed with oral agent monotherapy in UK primary care from 1998 to 2004...
  11. ncbi The impact of osteoporosis on quality-of-life: the OFELY cohort
    A R Martin
    Merck Research Laboratories, West Point, PA, USA
    Bone 31:32-6. 2002
    ..Recognition of the impact of Op-related factors on QoL may help health-care providers more fully appreciate the importance of prevention and treatment...
  12. ncbi Development of a health-related quality of life questionnaire for women with androgenetic alopecia
    K S Dolte
    Department of Epidemiology, Merck Research Laboratories, Blue Bell, Pennsylvania, USA
    Clin Exp Dermatol 25:637-42. 2000
    ....
  13. ncbi Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
    Tobias Pischon
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
    Circulation 112:3375-83. 2005
    ....
  14. ncbi Treatment escalation and rise in HbA1c following successful initial metformin therapy
    Gregory A Nichols
    Kaiser Permanente Center for Health Research, 3800 N Interstate Avenue, Portland, OR 97227 1098, USA
    Diabetes Care 29:504-9. 2006
    ..To describe secondary failure of initial metformin therapy in patients who achieved initial HbA(1c) (A1C) <8% and to identify predictors of failure...
  15. ncbi Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study
    Ann Marie McNeill
    Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina 27514, USA
    J Am Geriatr Soc 54:1317-24. 2006
    ....
  16. ncbi The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study
    Ann Marie McNeill
    University of North Carolina, Chapel Hill, 137 E Franklin St, Chapel Hill, NC 28514, USA
    Diabetes Care 28:385-90. 2005
    ..To assess the magnitude of the association between the National Cholesterol Education Program's Third Adult Treatment Panel Report (ATP III) definition of the metabolic syndrome and cardiovascular disease (CVD)...
  17. ncbi Contemporary analysis of secondary failure of successful sulfonylurea therapy
    Gregory A Nichols
    Kaiser Permanente Center for Health Research, Portland, Oregon 97227 1098, USA
    Endocr Pract 13:37-44. 2007
    ..To revise older estimates of secondary failure that may no longer describe the contemporary pattern of sulfonylurea (SU) monotherapy and to identify predictors of such failure...
  18. ncbi Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men
    Tobias Pischon
    Department of Epidemiology, German Institute of Human Nutrition, Potsdam Rehbruecke, Arthur Scheunert Allee 114 116, 14558 Nuthetal, Germany
    Atherosclerosis 197:392-9. 2008
    ..This study examined whether inflammation adds to the prediction of coronary heart disease (CHD) beyond metabolic syndrome (MetS), and whether these associations differ between sexes...
  19. ncbi An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study
    Cynthia J Girman
    Department of Epidemiology, Merck Research Laboratories, West Point, PA 19486, USA
    Am J Epidemiol 162:438-47. 2005
    ....
  20. ncbi Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes
    Michael N Cook
    Department of Epidemiology, Merck Research Laboratories, Merck, BL 1 7, P O Box 4, West Point, PA 19486 0004, USA
    Diabetes Care 28:995-1000. 2005
    ..To describe the course and predictors of glycemic control among patients with type 2 diabetes after sulfonylureas (SUs) are added to metformin (MF)...
  21. ncbi Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study)
    Ann Marie McNeill
    Department of Epidemiology, University of North Carolina at Chapel Hill, 27514, USA
    Am J Cardiol 94:1249-54. 2004
    ..0001). Thus, MS was significantly associated with the presence of CHD and carotid intimal medial wall thickness. Identification of patients who have MS may provide opportunities to initiate CHD prevention strategies...
  22. ncbi The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
    Cynthia J Girman
    Departments of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    Am J Cardiol 93:136-41. 2004
    ..It appears that the metabolic syndrome is associated with risk that is not entirely accounted for by traditional risk scoring paradigms...
  23. ncbi Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community
    Rosebud O Roberts
    Department of Health Sciences Research and Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 80:759-64. 2005
    ..Extrapolation of findings from the placebo arm of clinical trials to describe the natural history of disease in community-dwelling men should be done with caution and appropriate recognition of limitations...
  24. ncbi A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer
    Rosebud O Roberts
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:219-25. 2002
    ..The stronger effect among older men suggests that NSAIDs may prevent the progression of prostate cancer from latent to clinical disease...
  25. ncbi Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men
    Aruna V Sarma
    Department of Urology and Epidemiology, University of Michigan, Ann Abor, USA
    J Urol 168:1446-52. 2002
    ..However, there remain some men with increases in frequency who do not report similar increases in bother, possibly representing some component of adaptation or acceptance of worsening symptom severity with age...
  26. ncbi Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men
    Aruna V Sarma
    Department of Urology, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 31:476-82. 2008
    ..The aim of this study was to examine associations between diabetes and clinical markers of benign prostatic hyperplasia (BPH) in community-dwelling white and black men aged 40-79 years...
  27. ncbi Prevalence of prostatitis-like symptoms in a community based cohort of older men
    Rosebud O Roberts
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 168:2467-71. 2002
    ..While pain measures may be useful in distinguishing between men with and without prostatitis-like symptoms, the urinary symptom and quality of life impact scores could partly reflect benign prostatic hyperplasia...
  28. ncbi Frequency of sexual activity and prostatic health: fact or fairy tale?
    Steven J Jacobsen
    Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 61:348-53. 2003
    ....
  29. ncbi Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia
    Rosebud O Roberts
    Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Epidemiol 157:784-91. 2003
    ..72, 95% CI: 1.05, 2.82), after simultaneous adjustment for IGF-I and age, but not with other urologic measures. These data do not provide evidence for an association between benign prostatic hyperplasia and serum IGF-I...
  30. ncbi Dropout in a longitudinal, cohort study of urologic disease in community men
    Naomi M Gades
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    BMC Med Res Methodol 6:58. 2006
    ..Factors associated with dropout were evaluated in a twelve-year community-based, prospective cohort study of urologic disease in men...
  31. ncbi Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia
    James P Burke
    Division of Epidemiology, Mayo Clinic, Rochester, MN, USA
    Am J Epidemiol 164:41-6. 2006
    ..These data provide no evidence of a consistent significant relation between anthropometric measures and BPH...
  32. ncbi Inverse association between prostate cancer and the use of calcium channel blockers
    Jose D Debes
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 13:255-9. 2004
    ..64 (0.82-8.47) in men with a family history of prostate cancer (P = 0.006). These findings suggest an association between prostate cancer and daily use of calcium channel blockers that varies by family history of prostate cancer...
  33. ncbi Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort
    Jennifer L St Sauver
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Eur Urol 50:105-11. 2006
    ..CONCLUSION: Tracking changes in TZV over time may be unlikely to provide a good surrogate measure for the development of benign prostatic hyperplasia...
  34. ncbi Association between dietary factors and plasma adiponectin concentrations in men
    Tobias Pischon
    Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Am J Clin Nutr 81:780-6. 2005
    ..However, little is known about dietary predictors of plasma adiponectin concentrations in humans...
  35. ncbi Effect of fracture on the health care use of nursing home residents
    Sheryl Zimmerman
    Cecil G. Sheps Center for Health Services Research, The School of Social Work, University of North Carolina at Chapel Hill, 27599-3386, USA
    Arch Intern Med 162:1502-8. 2002
    ..For patients who fractured a hip, higher use decreased after 6 months, similar to community cohorts. Nursing home residents who visit the emergency department may warrant special screening for a fracture...